Search for Clinical Trial Results

Sponsored By

Cholesterol Ester Storage Disease - 25 Studies Found

Status Study
Completed Study Name: An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Condition:
  • Cholesterol Ester Storage Disease(CESD)
  • Lysosomal Acid Lipase D
    Date: 2012-02-01
Recruiting Study Name: National Lysosomal Acid Lipase Deficiency Study
Condition: Cholesteryl Ester Storage Disease
Date: 2015-02-21
Recruiting Study Name: Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study
Condition:
  • Non-alcoholic Fatty Liver Disease
  • Cholesterol Ester Storage Disease Date: 2013-02-10
Recruiting Study Name: Identification of Undiagnosed Lysosomal Acid Lipase Deficiency
Condition:
  • Lysosomal Acid Lipase Deficiency
  • Cholesterol Ester Storage Disease Date: 2012-10-26
    Interventions: Other: enzyme analysis
Completed Study Name: Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up
Condition:
  • Wolman Disease
  • Cholesterol Ester Storage Disease
  • Date: 2013-03-13
    Interventions: Other: There are no interventions in this study.
Active, not recruiting Study Name: Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency
Condition:
  • Cholesterol Ester Storage Disease(CESD)
  • Lysosomal Acid Lipase D
    Date: 2011-11-26
    Interventions:
    • Drug: SBC-102 (sebelipase alfa)

Completed Study Name: Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Patients With Lysosomal Acid Lipase Deficiency
Condition:
  • Cholesterol Ester Storage Disease(CESD)
  • Lysosomal Acid Lipase D
    Date: 2011-03-01
    Interventions:
    • Drug: SBC-102 (sebelipase alfa)

Active, not recruiting Study Name: A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)
Condition:
  • Cholesterol Ester Storage Disease (CESD)
  • Lysosomal Acid Lipase
    Date: 2012-12-17
    Interventions:
    • Drug: SBC-102 [sebelipase alfa] (1 mg/kg)
Recruiting Study Name: Biomarker for Wolman Disease
Condition:
  • Wolman Disease
  • Acid Lipase Deficiency
  • Acid Cholesteryl Est
    Date: 2015-03-03
Recruiting Study Name: Lysosomal Acid Lipase (LAL) Deficiency Registry
Condition:
  • Lysosomal Acid Lipase Deficiency
  • Cholesterol Ester Storage Disease Date: 2012-06-29
Next >>>